Biopharmaceutical Company.
H.R. 6: 21st Century Cures Act.

Education about the value of innovative new medicines. Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program and proposed changes to cost sharing for low income seniors.

H.R.5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

March 2016 CMS proposed rule implementing a new Part B drug payment model.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX